Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 1 Trials for Pirfenidone (DB04951)

Also known as: Obliterative Bronchiolitis / Bronchiolitis Obliterans / Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans Syndrome / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03315741The Safety and Tolerability of Pirfenidone for BOS After HCTTreatment